Allergy vaccines
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Dec 12, 2002
app pub date -
Dec 27, 2001
filing date -
Dec 28, 2000
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The use of a derivative of an allergenic protein is disclosed whereby the derivative has a reduced allergenic activity compared with the allergenic protein from which it is derived for the preparation of a medicament for the treatment or prevention of an allergic disorder, wherein the medicament is administered to a patient two to six times with the proviso that the time intervals between the administrations are at least 14 days and the medicament induces blocking antibodies.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully